Concepts (88)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sobhan Roy's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sobhan Roy has written about over time.
Antigens, BacterialGlycoproteinsAntigen PresentationAntigens, CD1LipidsMycobacteriumReceptors, Antigen, T-Cell, alpha-betaMycobacterium tuberculosisT-Lymphocyte SubsetsMucosal-Associated Invariant T CellsT-LymphocytesCrystallography, X-RayReceptors, Antigen, T-Cell, gamma-deltaMucinsLymphocyte ActivationAntigens, CDButyrophilinsHLA-B AntigensProteomeReceptors, KIR2DL2
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Antigens, Bacterial | 2 | 2013 | 2014 | December 2013 |
| Glycoproteins | 2 | 2013 | 2016 | August 2014 |
| Antigen Presentation | 3 | 2013 | 2016 | September 2014 |
| Antigens, CD1 | 3 | 2013 | 2016 | September 2014 |
| Lipids | 1 | 2014 | 2014 | October 2014 |
| Mycobacterium | 1 | 2014 | 2014 | October 2014 |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2014 | 2014 | October 2014 |
| Mycobacterium tuberculosis | 2 | 2013 | 2016 | January 2015 |
| T-Lymphocyte Subsets | 1 | 2016 | 2016 | January 2016 |
| Mucosal-Associated Invariant T Cells | 2 | 2016 | 2019 | April 2018 |
| T-Lymphocytes | 7 | 2013 | 2025 | January 2019 |
| Crystallography, X-Ray | 3 | 2014 | 2025 | October 2019 |
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2016 | 2025 | March 2021 |
| Mucins | 1 | 2021 | 2021 | September 2021 |
| Lymphocyte Activation | 3 | 2016 | 2025 | December 2021 |
| Antigens, CD | 1 | 2025 | 2025 | April 2025 |
| Butyrophilins | 1 | 2025 | 2025 | April 2025 |
| HLA-B Antigens | 1 | 2025 | 2025 | July 2025 |
| Proteome | 1 | 2025 | 2025 | July 2025 |
| Receptors, KIR2DL2 | 1 | 2025 | 2025 | July 2025 |
To return to the timeline,
click here.